China’s Evergrande, a Chinese real estate developer, has been granted one final opportunity to reorganize its debt. According to MarketWatch, the Hong Kong court has given the company time till December 4 to produce a new debt restructuring plan before reconsidering its liquidation. Judge Linda...

Pfizer has declared that following encouraging preliminary findings in an early to mid-stage investigation, its combination vaccine candidates targeting Covid and the flu will advance to a final-stage trial in the upcoming months.   This brings the multinational pharmaceutical company and...

Healthcare organisations that make money from treating patients who are overweight or obese are attempting to persuade investors that potent new medications for weight loss won't negatively impact their operations.   Because Novo Nordisk's Wegovy and other similar medications are so...

According to the Italian corporation, Pirelli and Saudi Arabia's Public Investment Fund (PIF) have inked a joint venture deal to establish a tire production facility in the country. The venture is scheduled to begin operations in 2026. PIF will own seventy-five percent of the joint venture (JV),...

Amid an investigation into key Apple supplier Foxconn, China's government stated on Wednesday that Taiwanese enterprises should take up their social obligations and play a "positive role" in fostering the peaceful development of relations across the Taiwan Strait.   The front-runner for...

Beijing is considering delaying the $69 billion acquisition of cloud computing startup VMware Inc. by American chipmaker Broadcom Inc., the Financial Times reported on Thursday, citing three people with knowledge of the situation.   According to the article, China's State Administration of...

Due to economic uncertainty and concerns about a potential slowdown in demand, Tesla has joined General Motors and Ford in exercising caution when it comes to increasing the capacity for producing electric vehicles (EVs).   Elon Musk, the CEO of Tesla, expressed concern that increased...

Lower sales of anti-coronavirus medications have caused American pharmaceutical major Pfizer Inc. to decrease its financial projection for 2023. The corporation projects its revenue for 2023 to be in the range of $58–61 billion instead of the $67–70 billion that was originally anticipated. The...

Due to the growing tension between Israel and the Palestinian organization "Hamas" and the resulting increase in pricing, many LNG purchasers in Asia decide to put off making additional purchases for the winter, writes Bloomberg. The buyers claim that Asian gas reserves are comfortably high enough...